Adaptive Biotechnologies Corporation announced that Tycho Peterson will depart the company as CFO. Kyle Piskel, the company's Principal Accounting Officer, will succeed Peterson as full-time CFO. Piskel served as the company's interim CFO from February to June 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.755 USD | -3.72% | +6.46% | -22.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.65% | 575M | |
-29.62% | 9.84B | |
-0.26% | 3.15B | |
+27.31% | 2.99B | |
-14.73% | 2.15B | |
-14.18% | 1.8B | |
+70.01% | 1.49B | |
+23.42% | 770M | |
-2.84% | 762M | |
+5.37% | 308M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Announces CFO Changes